Suma Ramadas, PhDMedical Affairs
David LinetskyPoint-of-Care Marketing
Pat PurcellMeeting Engagement
Matthew DurhamOmnidynamic Marketing
Amy GilesIncreasing Engagement
Brenda SnowAuthentic Patient Voice
Liz KaneImpactful Strategy
Daniel SontupeMarket Access
Bud BilanichSuccess Coach
Stacey GandlerBrand Nourishment
Paul TheisenPatient Acquisition
Joey CohenMedication Adherence
Frank BurrellScientific Storytelling
Matt TurnerPatient Affordability
ODYSSEY OUTCOMES investigators highlight at AHA that Praluent® (alirocumab) was associated with fewer deaths ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email